ArticlemedRxiv : the preprint server for health sciences2025
A novel model to predict age of respiratory syncytial virus infection from birth timing in relation to RSV circulation.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
8 authors.
Funding
Abstract
Respiratory syncytial virus (RSV) is a common respiratory virus that infects all children by age 2 to 3 years of age and causes the greatest morbidity at the extremes of life. Recent evidence suggests that early-life RSV infection, defined using active and passive surveillance with quantitative polymerase chain reaction- and serology-identified infection, is causal for childhood asthma. As such, identifying infants that are likely to be infected with RSV during this critical susceptibility window has important implications for determining who is most at risk for chronic respiratory sequelae like asthma. However, identifying the age of RSV infection is impractical in large populations, as not all infections are symptomatic, and measurement thus requires time- and cost-intensive surveillance. To address this, we developed the first probability model for age of first RSV infection. It uses an infant's birthdate, demographic covariates, and publicly available RSV circulation data to determine the probability they were first infected at any age from birth to one year. Our model is easy to interpret, provides an exceptional fit for the data, and generalizes across populations, where we use it to accurately predict age of first infection in two independent cohorts. Our work represents a major development in RSV research, as it facilitates, for the first time, reliable estimation of the age of infant RSV infection during the first year of life in populations without the need for active surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.